Methodological quality of the review: Low confidence
Author: West LA, Oren AG, Moroi SE.
Region: Worldwide
Sector: Cataract, age-related macular degeneration (AMD), glaucoma and diabetic retinopathy
Sub-sector: Preventing/slowing progression
Type of cataract: Age-related cataract
Equity focus: None specified
Review type: Other review
Quantitative synthesis method: Narrative analysis
Qualitative synthesis methods: Not applicable
Background
As the use of complementary and alternative medicine is growing, including in relation to eye diseases, it is important for ophthalmologists to know the evidence for the role of nutritional supplements and herbal medicines in common eye diseases.
Research objectives
To review the evidence for the role of nutritional supplements and herbal medicines in preventing, treating or delaying progression of age related macular degeneration, cataract, diabetic retinopathy and glaucoma.
Main findings
Authors included 23 studies which analysed the use of nutritional and herbal supplements in the treatment of common eye conditions. These were conducted in USA, Australia, Barbados, France, Finland and China.
The available evidence did support the use of certain vitamins and minerals in patients with certain forms of age-related macular degeneration. For cataracts, the available evidence did not support these supplements to prevent or treat cataracts in healthy individuals. For diabetic retinopathy and glaucoma, the available evidence did not support the use of these supplements. In the category of herbal medicines, the available evidence did not support the use of herbal medicines for any of these ocular diseases.
Because of the widespread use of nutritional supplements and herbal medicines, authors noted that ophthalmologists should be aware of their use so that they can inform patients properly when the supplements and herbal medicine are being used for eye disease. They also stated that a well-designed multicentre clinical trial on the use of nutritional supplements in eye disease is unlikely to be funded as prescription drug trials are the priority for research for most interested funders.
Methodology
Published studies and information found in PUBMED, International Bibliographic Information of Dietary Supplements, and selected websites were reviewed for the role of nutritional and herbal medicines in the treatment of age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma. The studies were evaluated systematically for their study design, study population, benefits, risks, biases, and criteria for the categorization of the level of evidence. Studies were evaluated for their level of evidence as level I, II or III based on the American Academy of Ophthalmology (AAO) guidelines. Only studies with level of evidence I or II were reported in the paper.
Applicability/external validity
The authors did not discuss the applicability/external validity of the results.
Geographic focus
Although authors included data from all income settings, results were mostly from high-income countries. The use of complementary supplements was likely to be much greater in high-income countries, therefore policy recommendations from this study might not be valid in low- or middle-income countries where patients do not have access to the supplements.
Quality assessment
This review was given low confidence in conclusions about the effects analysed as major limitations were identified. The review lacked clear outcomes for the search, inclusion criteria is not clearly reported and there was no evidence of more than one reviewer screening full-text articles for inclusion or extracting data of included studies. No sensible criteria were used to address bias, and the review was limited to a narrative summary of findings without appropriate discussion of the factors responsible for the differences in the results of the studies included. Additionally, the interpretation of the findings and conclusion were not clear.
Publication Details
West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006 Jan;141(1):157-66.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.